PolyPid Ltd.
USD3.74
-1.41 (-27.38%)
CEO
Dikla Czaczkes Akselbrad
IPO Date
2020-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$4.77
Prev. Close
$5.15
Day Low
$3.72
Day High
$4.77
52W Low
$3.06
52W High
$5.73
Market Cap
$0.04B
Volume
2.21M
| 49,000 |
| $4.46 |
| 17 Jul 2026 | Hazan Dalit Fellous | Deputy CEO, EVP, RD, CRA | A-Award | Acquired | 75,000 | $4.46 |
| 17 Jul 2026 | Barenholz Yechezkel | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | Stein Robert Benjamin | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | Dror-Darwish Nir | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | BenAmram Joseph | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | Krinsky Itzhak | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | Story Brooke | director | A-Award | Acquired | 9,132 | $4.46 |
| 17 Jul 2026 | Akselbrad Dikla Czaczkes | director, officer: Chief Executive Officer | A-Award | Acquired | 149,000 | $4.46 |